martes, 10 de septiembre de 2019

Cancer drug approvals in the U.S. have surged - STAT

Cancer drug approvals in the U.S. have surged - STAT

Cancer Briefing

STAT Plus: Cancer drug approvals in the U.S. have surged over the past few decades

By ED SILVERMAN


ADOBE
The portion of new oncology drugs approved by the FDA swelled over the past decade, reaching 27% of all approvals compared with just 4% during the 1980s.

No hay comentarios: